Cargando…

Impact of Obesity on Microvascular Obstruction and Area at Risk in Patients After ST-Segment-Elevation Myocardial Infarction: A Magnetic Resonance Imaging Study

BACKGROUND: Better survival for overweight and obese patients after ST-segment elevation myocardial infarction (STEMI) has been demonstrated. The association between body mass index (BMI), microvascular obstruction (MVO), and area at risk (AAR) after STEMI was evaluated. METHODS: A prospective obser...

Descripción completa

Detalles Bibliográficos
Autores principales: Lan, Di-Hui, Zhang, Yue, Hua, Bing, Li, Jin-Shui, He, Yi, Chen, Hui, Li, Wei-Ping, Li, Hong-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9342698/
https://www.ncbi.nlm.nih.gov/pubmed/35923250
http://dx.doi.org/10.2147/DMSO.S369222
Descripción
Sumario:BACKGROUND: Better survival for overweight and obese patients after ST-segment elevation myocardial infarction (STEMI) has been demonstrated. The association between body mass index (BMI), microvascular obstruction (MVO), and area at risk (AAR) after STEMI was evaluated. METHODS: A prospective observational study was performed to enrolled patients undergoing primary percutaneous coronary intervention (pPCI) for STEMI and cardiac magnetic resonance was performed within 5–7 days. Patients were classified as normal weight (18.5 ≤BMI <24.0 kg/m(2)), overweight (24.0 ≤BMI <28.0 kg/m(2)), or obese (BMI ≥28 kg/m(2)). RESULTS: Among 225 patients undergoing pPCI, 67 (30.00%) were normal weight, 113 (50.22%) were overweight, and 45 (20.00%) were obese. BMI ≥28 kg/m(2) was significantly associated with less risk of MVO when compared with a normal BMI after multivariable adjustment (overweight: HR 0.29, 95% CI 0.13–0.68, p = 0.004). Compared with normal weight patients, obese and overweight patients tend to have larger hearts (greater left ventricular end-diastolic volume [LVEDV] and left ventricular [LV] mass). In adjusted analysis, increased BMI was significantly associated with a smaller AAR. In addition, obese patients had a smaller AAR (β = −0.252, 95% CI −20.298- −3.244, p = 0.007) and AAR, % LV mass (β = −0.331, 95% CI −0.211- −0.062, p < 0.001) than normal weight patients. CONCLUSION: Obesity (BMI ≥28 kg/m(2)) is independently associated with lower risks of MVO and a smaller AAR, % LV mass than normal weight patients among subjects undergoing pPCI for STEMI.